Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bassan

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|January 15, 1986
Induction of cytotoxicity by interleukin-2 in T gamma-lymphoproliferative disordersP Allavena, M Introna, A Rambaldi, et al.
British Journal of Haematology|March 1, 1992
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemiaG Specchia, V Liso, S Capalbo, et al.
Arquivos Brasileiros De Cardiologia|October 1, 1994
[Early and delayed cardiac mortality after acute myocardial infarction in the pre-thrombolytic era. Prognosis value of an ergometric test and coronary arteriography]R Bassan, C de B Ferreira, M E Santos, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1986
Migratory capacity of large granular lymphocytes from T-gamma-lymphoproliferative disordersB Bottazzi, A Rambaldi, M Introna, et al.
Environmental Pollution (Barking, Essex : 1987)|June 26, 2009
Long-term air monitoring of organochlorine pesticides using Semi Permeable Membrane Devices (SPMDs) in the AlpsW Levy, B Henkelmann, G Pfister, et al.
Leukemia & Lymphoma|October 29, 2002
Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patientsB Petit, L Mele, K Rack, et al.
Hematological Oncology|January 1, 1985
Treatment of acute lymphoblastic leukemia in adultsT Barbui, R Bassan, T Chisesi, et al.
Hematological Oncology|July 1, 1993
Reinforced HEAV'D therapy for adult acute lymphoblastic leukemia: improved results and revised prognostic criteriaR Bassan, R Battista, A Montaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysisM Bregni, S Siena, A Neri, et al.
Haematologica|August 27, 1998
Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemiaR Bassan, R Raimondi, T Lerede, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|January 15, 1986
Induction of cytotoxicity by interleukin-2 in T gamma-lymphoproliferative disordersP Allavena, M Introna, A Rambaldi, et al.
British Journal of Haematology|March 1, 1992
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemiaG Specchia, V Liso, S Capalbo, et al.
Arquivos Brasileiros De Cardiologia|October 1, 1994
[Early and delayed cardiac mortality after acute myocardial infarction in the pre-thrombolytic era. Prognosis value of an ergometric test and coronary arteriography]R Bassan, C de B Ferreira, M E Santos, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1986
Migratory capacity of large granular lymphocytes from T-gamma-lymphoproliferative disordersB Bottazzi, A Rambaldi, M Introna, et al.
Environmental Pollution (Barking, Essex : 1987)|June 26, 2009
Long-term air monitoring of organochlorine pesticides using Semi Permeable Membrane Devices (SPMDs) in the AlpsW Levy, B Henkelmann, G Pfister, et al.
Leukemia & Lymphoma|October 29, 2002
Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patientsB Petit, L Mele, K Rack, et al.
Hematological Oncology|January 1, 1985
Treatment of acute lymphoblastic leukemia in adultsT Barbui, R Bassan, T Chisesi, et al.
Hematological Oncology|July 1, 1993
Reinforced HEAV'D therapy for adult acute lymphoblastic leukemia: improved results and revised prognostic criteriaR Bassan, R Battista, A Montaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysisM Bregni, S Siena, A Neri, et al.
Haematologica|August 27, 1998
Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemiaR Bassan, R Raimondi, T Lerede, et al.
Pageof 11